SK바이오팜326030

주관 임상 단계 분포

FDA 승인

• 2019-11-21

  XCOPRI

  CENOBAMATE

  NDA212839

진행 중인 임상

• 4상모집 중단 (진행 중)· Focal Onset Seizure

  Open-label Study of Cenobamate Monotherapy in Adult Subjects With Newly Diagnosed or Recurrent Partial-Onset Epilepsy

  NCT06453213
• 3상모집 중· Seizures

  Investigate Efficacy and Safety of Carisbamate as Adjunctive Treatment for Seizures Associated With LGS in Children and Adults

  NCT05219617
• 3상모집 중단 (진행 중)· Partial Epilepsy

  Safety and Efficacy Study of Cenobamate in Pediatric Subjects 2-17 Years of Age With Partial-onset (Focal) Seizures

  NCT05067634